Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells
about
Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndromeSynergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsThe Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and TreatmentDoxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused miceNo beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan miceDevelopment of a novel murine model of aortic aneurysms using peri-adventitial elastase.Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture.Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosisTime-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbiditiesBeneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune SystemAnalysis of positional candidate genes in the AAA1 susceptibility locus for abdominal aortic aneurysms on chromosome 19.Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats.MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance.In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rateDoxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin IIDoxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study.Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression.A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammationACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysmNovel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans.GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary.Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm.Effects of prolonged vaginal distension and β-aminopropionitrile on urinary continence and urethral structure.Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention studyClonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.Differential gene expression in human abdominal aortic aneurysm and aortic occlusive diseaseMatrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.Chronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome.Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicineTetracycline inhibits local inflammation induced by cerebral ischemia via modulating autophagy.Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.Intracranial aneurysm formation in type-one diabetes ratsDoxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts.Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice.
P2860
Q24631384-7327070F-7325-4FD9-B4B6-6570CC6F747CQ24631610-513F1406-2DCA-4059-8679-6D96257EF28AQ26776131-4A8A0322-5826-4B6A-9598-9892B6E4ACDFQ28484080-8C242656-8655-4DBA-A4C4-D9F931CEFB84Q28543088-105672EF-8985-4485-87D4-B34977071FA1Q30421868-351A7AAE-5DAA-4640-9B8B-481FC407048EQ30422894-02FE5850-3EF0-439B-9504-D96089A6DB32Q30502726-CEF936D7-E2D2-465D-8A3D-2C90D57E8677Q33526310-0F2CBE72-4823-469F-9392-60762C82EEDBQ33567788-22B07067-5B59-40B0-8756-5D3D58EF3573Q33651788-95AFF9DD-E977-4457-8225-8E1CCCAD0837Q33664362-905D881F-A26C-40FF-B97A-372388DA76F8Q33797335-E9C07D00-BECC-4DCA-A828-BC4CBFCF160AQ33886784-FE424305-5ABD-4790-9880-EAAFAF64BF97Q33967006-4737E757-0B15-43A7-BC38-BA67C6A7CE9FQ34103996-1AD03A4F-0181-4AFF-B3F1-A7E3A22DFF62Q34255402-7E86FE57-5D9C-4943-B8A9-80CDAF6E8DD6Q34311153-9DFFDD60-9D0D-4F42-8516-146758D7F559Q34372745-625ADE44-600B-4CD9-ABBF-8E2B7BC44F68Q34506416-B2F5AEBC-6986-4150-B3BE-6979F783502AQ34532189-78641D83-8BE3-4BCD-89BA-E3805C05D9EAQ34562390-30DF2545-E292-4E8F-AFBF-EA7B3FFC1967Q34634364-83B26188-A4E5-428C-839F-F207FE125761Q34682737-AD2AC873-9AA4-4AF5-8253-30460A11BAAAQ35001269-2B6C5238-EEE6-4562-82B6-8FC6E9186E9DQ35126452-23BCB27E-C8B1-4C32-A534-86731EE171D4Q35327288-F02E2803-DAB2-467B-A4D0-E6EA2AB1703EQ35676456-C57E129F-8A36-4557-AD7F-007AC1AF540EQ35723666-59585B6B-24BF-4042-B32D-F7C06E945F6EQ35843863-C5EB6373-FD72-43F5-B543-F8A970E272D1Q35955181-809DAAF0-6ABA-414D-A5C0-23E940FCA4E0Q36009930-EA322D4F-E689-46D9-B9E0-792D542765E5Q36123018-D65EA908-59D2-4D00-BD56-135B5FA4F795Q36296835-3A78347E-C97B-4599-BBA8-227FFC5BE0FCQ36317523-435424C6-501E-4013-86D1-9AEA3C0F8B8BQ36381245-AD90B339-2CE1-4ACB-84DA-0AB450791CC8Q36599238-8526C217-48DF-499B-8FB3-38B70AE026DCQ36976259-0B1CF451-B426-4F4A-AA67-B073857053D8Q37013567-20C0EBF9-811A-4127-B14D-D27273030C18Q37251630-116DFC59-8484-4165-BB1C-4584A398922E
P2860
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@ast
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@en
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@nl
type
label
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@ast
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@en
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@nl
prefLabel
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@ast
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@en
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@nl
P2093
P3181
P1433
P1476
Clinical trial of doxycycline ...... trophils and cytotoxic T cells
@en
P2093
Hazem Abdul-Hussien
J Hajo van Bockel
Jan H N Lindeman
Robert Kleemann
Ron Wolterbeek
P304
P3181
P356
10.1161/CIRCULATIONAHA.108.806505
P407
P577
2009-04-28T00:00:00Z